---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-116484"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-11-05T22:50:37+00:00"
generated_at: "2026-11-06T11:06:06.354375+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics gets Nasdaq bid-price notice; TPST has until May 3, 2027 to top $1.00

## Summary
- Nasdaq Listing Qualifications Staff letter dated Nov. 4, 2026: TPST common stock closed below $1.00 for the last 30 consecutive business days, violating Rule 5550(a)(2).
- Company has 180 calendar days, until May 3, 2027, to regain compliance; requires a closing bid of at least $1.00 for a minimum of 10 consecutive business days.
- Notice has no immediate effect on the Nasdaq listing of TPST shares or on business operations, per the filing.
- If not cured by May 3, 2027, Tempest may qualify for a second 180-day period if it meets market-value and other Capital Market standards and signals a reverse split if needed.
- Company said it will actively monitor its closing bid price and evaluate options to resolve the deficiency; CEO Matthew Angel signed the filing Nov. 5, 2026.

## SEC filing metadata
- accession: 0001213900-26-116484
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-11-05T22:50:37+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000121390026116484/0001213900-26-116484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000121390026116484/ea0311157-8k_tempest.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-116484
- JSON: https://secwatch.observer/filing/0001213900-26-116484.json
- Plain text: https://secwatch.observer/filing/0001213900-26-116484.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.